Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. The bactericidal action of vancomycin results primarily from inhibition of cell-wall ...

Researchers have identified the specific mechanism that triggers resistance to vancomycin. A new study led by the scientific director of the Michael G. DeGroote Institute for Infectious Disease ...

Furthermore, the evidence consistently demonstrated that the onset of vancomycin-induced neutropenia occurred with prolonged use. The exact mechanism of vancomycin-induced neutropenia is unknown ...

Patients receiving oral vancomycin therapy were identified as having CDAD, the only indication for this drug. Each case subject was matched with up to 10 control subjects. Neither the cases nor the ...